Acurx Pharmaceuticals, Inc. Public Float
Acurx Pharmaceuticals, Inc. (ACXP) had Public Float of $13.70 million as of 2025-06-30, per its 10-K filed 2026-03-12.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-12
- 2025-06-30: Entity Public Float $13.70M.
- 2024-06-30: Entity Public Float $30.60M.
- 2023-06-30: Entity Public Float $27.90M.
- 2022-06-30: Entity Public Float $29.80M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $13.70M 10-K · filed 2026-03-12 |
| 2024-06-30 | $30.60M 10-K · filed 2025-03-17 |
| 2023-06-30 | $27.90M 10-K · filed 2024-03-15 |
| 2022-06-30 | $29.80M 10-K · filed 2023-03-15 |
| 2021-06-30 | $48.10M 10-K · filed 2022-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B |